https://www.bariatricpal.com/news/medications/semaglutide-lifespan-female-mice-late-life/ 2026-09-03T23:19:00+00:00 Obesity Treatment News en 2026-09-03T23:19:00+00:00 Semaglutide begun in old age extended median lifespan about 12 percent in female mice, the only sex tested https://www.bariatricpal.com/news/regulatory/fda-warning-letters-research-peptide-sellers/ 2026-09-03T23:19:00+00:00 Obesity Treatment News en 2026-09-03T23:19:00+00:00 FDA warns four peptide sellers over semaglutide, tirzepatide and retatrutide sold as research chemicals https://www.bariatricpal.com/news/medications/weight-regain-after-stopping-semaglutide-tirzepatide/ 2026-09-03T17:13:00+00:00 Obesity Treatment News en 2026-09-03T17:13:00+00:00 Pooled trial data put weight regain after stopping semaglutide or tirzepatide near 1 kg a month https://www.bariatricpal.com/news/practice/excess-weight-metrics-misrepresent-surgery-results/ 2026-09-03T17:13:00+00:00 Obesity Treatment News en 2026-09-03T17:13:00+00:00 Common surgery weight-loss percentages overstate results, and none predicted six-month blood sugar https://www.bariatricpal.com/news/surgery/robotic-duodenal-switch-readmission-registry/ 2026-09-03T11:39:00+00:00 Obesity Treatment News en 2026-09-03T11:39:00+00:00 Robotic duodenal switch had a higher 30-day readmission rate than laparoscopic in a 17,615-case registry https://www.bariatricpal.com/news/surgery/ten-year-weight-trajectory-uk-bariatric-patients/ 2026-09-03T11:39:00+00:00 Obesity Treatment News en 2026-09-03T11:39:00+00:00 UK ten-year records show weight loss peaking near 31% at two years, then settling around 25% https://www.bariatricpal.com/news/practice/sleeve-versus-semaglutide-liver-markers/ 2026-09-03T11:39:00+00:00 Obesity Treatment News en 2026-09-03T11:39:00+00:00 Sleeve patients lost three times more weight than semaglutide patients, and liver stiffness fell about the same https://www.bariatricpal.com/news/medications/glp1-weight-loss-evidence-updated-review/ 2026-09-03T11:39:00+00:00 Obesity Treatment News en 2026-09-03T11:39:00+00:00 Review of 38 trials puts tirzepatide at 19% and semaglutide near 15% weight loss above placebo https://www.bariatricpal.com/news/regulatory/lipofit-fat-burner-recall-dnp-fluoxetine/ 2026-09-02T22:14:00+00:00 Obesity Treatment News en 2026-09-02T22:14:00+00:00 FDA testing found an antidepressant and a banned industrial chemical in a fat burner sold online https://www.bariatricpal.com/news/practice/pregnancy-surgical-emergencies-after-bariatric-surgery/ 2026-09-02T22:14:00+00:00 Obesity Treatment News en 2026-09-02T22:14:00+00:00 Every pregnancy surgical emergency in a Belgian bariatric study followed an intestine-rerouting operation https://www.bariatricpal.com/news/surgery/endoscopic-sleeve-versus-oral-semaglutide/ 2026-09-02T22:14:00+00:00 Obesity Treatment News en 2026-09-02T22:14:00+00:00 Endoscopic sleeve beat the semaglutide pill at six months, then the gap closed by one year https://www.bariatricpal.com/news/surgery/extreme-obesity-bmi-60-surgery-outcomes/ 2026-09-02T22:14:00+00:00 Obesity Treatment News en 2026-09-02T22:14:00+00:00 Registry of 1.26 million bariatric patients finds higher risk above BMI 70, with absolute rates still low https://www.bariatricpal.com/news/regulatory/california-sb-1089-glp1-calrx-enrolled/ 2026-09-02T05:05:49+00:00 Obesity Treatment News en 2026-09-02T05:05:49+00:00 California's GLP-1 pricing bill reached the governor as an authorization, not a coverage mandate https://www.bariatricpal.com/news/regulatory/fifth-circuit-compounded-glp1-shortage-rulings/ 2026-09-02T05:04:49+00:00 Obesity Treatment News en 2026-09-02T05:04:49+00:00 Fifth Circuit upholds the FDA shortage decisions that closed off compounded semaglutide and tirzepatide https://www.bariatricpal.com/news/medications/zepbound-healthcare-cost-trends-older-adults/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/medications/mounjaro-fda-cardiovascular-risk-indication/ 2026-08-31T13:50:07+00:00 https://www.bariatricpal.com/news/regulatory/medicare-discount-exclusions/ 2026-08-31T13:18:36+00:00 https://www.bariatricpal.com/news/regulatory/gray-market-retatrutide-safety/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/roche-hanmi-muscle-preserving-deal/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/oasis5-low-dose-oral-wegovy/ 2026-08-31T13:18:36+00:00 https://www.bariatricpal.com/news/medications/foundayo-uk-launch/ 2026-08-31T13:18:36+00:00 https://www.bariatricpal.com/news/medications/medicaid-glp1-use-state-coverage-policy/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/mazdutide-us-phase2-obesity/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/dual-glp1-glucagon-agonists-meta-analysis/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/practice/obesity-definition-framework/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/practice/medicine-vs-surgery-combo/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/preop-glp1-surgery/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/step12-semaglutide-chinese-adults/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/amazon-pharmacy-bridge-delivery/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/men-mbs-sex-differences/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/acp-obesity-access/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/zenagamtide-subcutaneous-phase2-diabetes/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/retatrutide-triumph-3-acc/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/surgery/ottava-robotic-fda/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/novo-v-lilly-ad-suit/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-adolescents-rising/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/remain-1-revita/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/intraoperative-liver-biopsy-bariatric-surgery/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/wegovy-pill-european-commission-approval/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/adolescent-mbs-louisiana/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/express-scripts-zepbound-formulary/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/medicare-glp1-bridge/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/bariatric-surgery-pharmacotherapy-cardiovascular-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/aga-power-2/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/acp-living-guideline-first-line/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/retatrutide-transcend-t2d-1/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/fda-unapproved-glp1-june-update/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/mhra-oral-wegovy-approval/ 2026-08-31T13:18:36+00:00 https://www.bariatricpal.com/news/medications/glp1-pancreatitis-signal/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/ecnoglutide-head-to-head/ 2026-08-31T13:18:36+00:00 https://www.bariatricpal.com/news/medications/survodutide-synchronize-1-nejm/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/medications/cagrisema-reimagine3-basal-insulin/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/cagrisema-reimagine2-phase3/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/cagrisema-reimagine1-phase3a/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/bariatric-surgery-arrhythmia-mortality-study/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-cancer-progression-asco/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/retatrutide-triumph-1-topline/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/surgery/jama-surgery-utilization-shift/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/glp1-discontinuation-maintenance-data/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/surmount-maintain-tirzepatide/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/surgery-vs-glp1/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/practice/asmbs-volume-untreated/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/asmbs-cost-vs-glp1/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/asmbs-ckd-cv/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/surgery-after-glp1/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/oral-ozempic-launch/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/oculus-glp1-upper-endoscopy/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/histori-semaglutide-antipsychotic-metabolic-trial/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-naion-risk-meta-analysis/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/regulatory/fda-503b-bulks-proposal/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/viking-vk2735-phase3/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/medicare-bridge-restructure/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/abdominoplasty-after-bariatric-surgery-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-afib-heart-rhythm-2026/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/orforglipron-achieve-4/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/semaglutide-cbt-aud-lancet/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/practice/obscore-risk-calculator/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/medicaid-glp1-patchwork/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/regulatory/foundayo-postmarketing-safety/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-nondiabetic-network-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/foundayo-orforglipron/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/wegovy-subscription-pricing/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/surgery/bariatric-surgery-mafld-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/pelvic-floor-bariatric-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/glp1-muscle-mass-cell-reports/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/wegovy-hd-72mg/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/bariatric-procedures-heart-failure-cohort/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/weight-recurrence-delphi-consensus/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/regulatory/fda-telehealth-warning-letters/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/medications/tos-compounded-tirzepatide-b12-safety-statement/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/petrelintide-zupreme1-phase2/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/psychological-trauma-bariatric-review/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/surgery/preoperative-glp1-bariatric-perioperative-meta-analysis/ 2026-08-31T03:20:33+00:00 https://www.bariatricpal.com/news/surgery/bariatric-sarcopenic-obesity-meta-analysis/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/tirzepatide-concomitant-weight-inducing-medications/ 2026-08-31T00:43:07+00:00 https://www.bariatricpal.com/news/medications/digital-microsteps-glp1-randomized-trial/ 2026-08-31T03:20:33+00:00